Repligen Corp
(RGEN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RGEN | PRAX | CYTK | ||
| Company | Repligen Corp | Praxis Precision Medicines Inc | Cytokinetics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 142.11 | 321.83 | 65.25 | ||
| High | 145.43 | 324.79 | 66.40 | ||
| Low | 137.41 | 302.00 | 63.53 | ||
| Latest | 139.51 | 317.83 | 66.33 | ||
| Change | -3.55 | -2.65 | +1.48 | ||
| % Change | -2.48% | -0.83% | +2.28% | ||
| Volume | 298,949 | 320,843 | 960,009 | ||
| 20-Day Average Volume | 686,087 | 545,990 | 1,557,647 | ||
| Previous Close | 143.06 | 320.48 | 64.85 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 154.88 | 310.83 | 63.85 | ||
| 20-Day Raw Stochastic | 5.72% | 73.16% | 84.32% | ||
| 20-Day Relative Strength | 34.00 | 59.05 | 54.67 | ||
| Weighted Alpha | -3.40 | +111.44 | +27.49 | ||
| Today's Opinion | 8% Buy | 100% Buy | 96% Buy | ||
| Previous Opinion | 8% Buy | 100% Buy | 88% Buy | ||
| Last Month's Opinion | 100% Buy | 88% Buy | 72% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.46% since 02/04/26 | +3.94% since 02/04/26 | +3.89% since 02/04/26 | ||
| Low | 137.46 on 02/11/26 | 297.27 on 02/05/26 | 60.05 on 02/05/26 | ||
| High | 147.16 on 02/05/26 | 328.60 on 02/09/26 | 66.00 on 02/11/26 | ||
| 1-Month | |||||
| %Chg | -16.32% since 01/09/26 | +9.31% since 01/09/26 | +5.57% since 01/09/26 | ||
| Low | 137.46 on 02/11/26 | 266.93 on 01/12/26 | 60.05 on 02/05/26 | ||
| High | 174.87 on 01/22/26 | 328.60 on 02/09/26 | 67.10 on 02/03/26 | ||
| 3-Month | |||||
| %Chg | -9.02% since 11/11/25 | +71.77% since 11/11/25 | -0.77% since 11/11/25 | ||
| Low | 137.46 on 02/11/26 | 160.11 on 11/21/25 | 58.85 on 01/05/26 | ||
| High | 175.77 on 01/06/26 | 328.60 on 02/09/26 | 70.98 on 12/22/25 | ||
| 6-Month | |||||
| %Chg | +24.78% since 08/11/25 | +601.45% since 08/11/25 | +98.59% since 08/11/25 | ||
| Low | 111.48 on 08/12/25 | 37.19 on 09/08/25 | 33.17 on 08/12/25 | ||
| High | 175.77 on 01/06/26 | 328.60 on 02/09/26 | 70.98 on 12/22/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,052,991 | 8,074,491 | 7,928,885 | ||
| Shares Outstanding, K | 56,291 | 25,195 | 122,265 | ||
| Annual Sales | 634,440,000 | 8,550,000 | 18,470,000 | ||
| Annual Net Income | -25,510,000 | -182,820,000 | -589,530,000 | ||
| Last Quarter Sales | 188,810,000 | 0 | 1,940,000 | ||
| Last Quarter Net Income | 14,910,000 | -73,930,000 | -306,180,000 | ||
| 60-Month Beta | 1.13 | 2.84 | 0.54 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.46 on 10/28/25 | -3.36 on 11/05/25 | -1.54 on 11/05/25 | ||
| Latest Earnings Date | 02/19/26 | 02/27/26 | 02/26/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 86.49 | 0.00 | 0.00 | ||